Wellington Management Group’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-298,763
| Closed | -$7.09M | – | 2325 |
|
|
2021
Q4 | $7.09M | Sell |
298,763
-340,086
| -53% | -$8.39M | ﹤0.01% | 1366 |
|
|
2021
Q3 | $16M | Sell |
638,849
-34,243
| -5% | -$872K | ﹤0.01% | 1143 |
|
|
2021
Q2 | $17.5M | Sell |
673,092
-156,253
| -19% | -$4.25M | ﹤0.01% | 1122 |
|
|
2021
Q1 | $21.2M | Sell |
829,345
-64,733
| -7% | -$1.66M | ﹤0.01% | 1056 |
|
|
2020
Q4 | $17.9M | Sell |
894,078
-94,286
| -10% | -$1.85M | ﹤0.01% | 1062 |
|
|
2020
Q3 | $16.9M | Sell |
988,364
-61,846
| -6% | -$1.17M | ﹤0.01% | 983 |
|
|
2020
Q2 | $22.9M | Buy |
1,050,210
+86,729
| +9% | +$1.99M | 0.01% | 895 |
|
|
2020
Q1 | $22.3M | Buy |
963,481
+8,293
| +0.9% | +$241K | 0.01% | 850 |
|
|
2019
Q4 | $31.5M | Buy |
955,188
+9,089
| +1% | +$291K | 0.01% | 874 |
|
|
2019
Q3 | $30.1M | Sell |
946,099
-140,915
| -13% | -$4.11M | 0.01% | 860 |
|
|
2019
Q2 | $27.9M | Buy |
1,087,014
+60,206
| +6% | +$1.53M | 0.01% | 928 |
|
|
2019
Q1 | $26.1M | Sell |
1,026,808
-20,959
| -2% | -$625K | 0.01% | 934 |
|
|
2018
Q4 | $35.7M | Buy |
1,047,767
+42,082
| +4% | +$1.37M | 0.01% | 821 |
|
|
2018
Q3 | $35.9M | Sell |
1,005,685
-710,158
| -41% | -$25.1M | 0.01% | 909 |
|
|
2018
Q2 | $59.2M | Sell |
1,715,843
-18,370
| -1% | -$644K | 0.01% | 738 |
|
|
2018
Q1 | $58.4M | Sell |
1,734,213
-189,944
| -10% | -$6.01M | 0.01% | 730 |
|
|
2017
Q4 | $73.5M | Sell |
1,924,157
-323,538
| -14% | -$12.9M | 0.02% | 662 |
|
|
2017
Q3 | $84.3M | Buy |
2,247,695
+162,663
| +8% | +$5.74M | 0.02% | 603 |
|
|
2017
Q2 | $77.8M | Buy |
2,085,032
+289,938
| +16% | +$10.5M | 0.02% | 591 |
|
|
2017
Q1 | $70.5M | Buy |
1,795,094
+922,268
| +106% | +$34.6M | 0.02% | 618 |
|
|
2016
Q4 | $30.4M | Buy |
872,826
+343,804
| +65% | +$13.5M | 0.01% | 866 |
|
|
2016
Q3 | $20.8M | Buy |
529,022
+85,862
| +19% | +$3.42M | 0.01% | 974 |
|
|
2016
Q2 | $16.8M | Buy |
443,160
+436,735
| +6,797% | +$14.6M | ﹤0.01% | 1006 |
|
|
2016
Q1 | $247K | Sell |
6,425
-5,475
| -46% | -$204K | ﹤0.01% | 2058 |
|
|
2015
Q4 | $572K | Sell |
11,900
-22,485
| -65% | -$1.04M | ﹤0.01% | 1956 |
|
|
2015
Q3 | $1.36M | Sell |
34,385
-10,901
| -24% | -$463K | ﹤0.01% | 1759 |
|
|
2015
Q2 | $1.93M | Sell |
45,286
-389,264
| -90% | -$15.5M | ﹤0.01% | 1681 |
|
|
2015
Q1 | $17.2M | Sell |
434,550
-349,868
| -45% | -$12.9M | ﹤0.01% | 1090 |
|
|
2014
Q4 | $28.3M | Sell |
784,418
-233,731
| -23% | -$7.85M | 0.01% | 931 |
|
|
2014
Q3 | $30M | Sell |
1,018,149
-120,559
| -11% | -$3.33M | 0.01% | 885 |
|
|
2014
Q2 | $28.6M | Buy |
1,138,708
+41,063
| +4% | +$1.02M | 0.01% | 912 |
|
|
2014
Q1 | $28.3M | Sell |
1,097,645
-322,278
| -23% | -$8.12M | 0.01% | 920 |
|
|
2013
Q4 | $31.9M | Sell |
1,419,923
-32,490
| -2% | -$627K | 0.01% | 873 |
|
|
2013
Q3 | $20.6M | Buy |
1,452,413
+1,378,644
| +1,869% | +$18.4M | 0.01% | 989 |
|
|
2013
Q2 | $1.01M | Buy |
+73,769
| New | +$1.01M | ﹤0.01% | 1764 |
|
Other funds holding NTUS
N
Wellington Management Group's NTUS Position: Q1 2022 in Review
Wellington Management Group sold out of Natus Medical Inc (NTUS) in Q1 2022, closing a stake of 298,763 shares — an estimated $7.09M sold.
Wellington Management Group first reported a position in NTUS in Q2 2013 and held it in 35 quarters. The position peaked at $84.3M in Q3 2017. 172 funds tracked by Wall St. Rank hold NTUS as of Q1 2022.
- Wellington Management Group reported no remaining Natus Medical Inc position as of Q1 2022 after selling out during the quarter.
- Wellington Management Group sold 298,763 Natus Medical Inc shares in Q1 2022, an estimated $7.09M.
- Wellington Management Group first reported a position in Natus Medical Inc in Q2 2013 and held it in 35 quarters.
- Wellington Management Group's Natus Medical Inc position peaked at $84.3M in Q3 2017.
- 172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2022.
Based on Wellington Management Group's 13F filing for Q1 2022, filed 16 May 2022.